Biologic disease-modifying anti-rheumatic drugs and kinase inhibitors: differences in efficacy and safety in rheumatoid arthritis Roy Fleischmann Editorial 24 September 2021 Pages: 4369 - 4372
Heel fat pad involvement in rheumatoid arthritis: a review and case series Eleni PilitsiEugene Kissin Review Article 04 April 2021 Pages: 4373 - 4377
Psoriatic arthritis and physical activity: a systematic review Julie KesslerMickael ChoukFrank Verhoeven Review Article 29 April 2021 Pages: 4379 - 4389
Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis Durga Prasanna MisraUpendra RathoreAman Sharma Review Article 01 May 2021 Pages: 4391 - 4416
Effects of resistance training on the mental health of patients with fibromyalgia: a systematic review Guilherme Torres VilarinoLeonardo Vidal AndreatoAlexandro Andrade Review Article 14 May 2021 Pages: 4417 - 4425
Disease activity indices in psoriatic arthritis: current and evolving concepts Chrysoula G. GialouriGeorge E. Fragoulis Review Article 18 May 2021 Pages: 4427 - 4435
PFAPA (periodic fever, aphthous stomatitis, pharyngitis, and adenitis) syndrome: an overview of genetic background Kosar Asna AshariNima Rezaei Review Article 20 May 2021 Pages: 4437 - 4444
Charcot knee — presentation, diagnosis, management — a scoping review Victor LuJames ZhangMatija Krkovic Review Article Open access 24 May 2021 Pages: 4445 - 4456
Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review Shunsuke MoriFumihiko OgataRyusuke Tsunoda Review Article Open access 23 September 2021 Pages: 4457 - 4471
Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology Graciela N. GómezNicolás PérezAmelia Granel Original Article 22 June 2021 Pages: 4473 - 4483
Can treating rheumatoid arthritis with disease-modifying anti-rheumatic drugs at the window of opportunity with tight control strategy lead to long-term remission and medications free remission in real-world clinical practice? A cohort study Sanaz EbrahimianAmin SalamiMehrzad Hajialilo Original Article 23 June 2021 Pages: 4485 - 4491
Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis Se Rim ChoiJun Won ParkJin Kyun Park Original Article 11 June 2021 Pages: 4493 - 4500
Genicular nerve block in rheumatoid arthritis: a randomized clinical trial A. M. ElsamanA. MaatyA. Hamed Original Article 02 July 2021 Pages: 4501 - 4509
Socioeconomic inequality in patients with rheumatoid arthritis: a systematic review and meta-analysis Nader SalariMohsen KazeminiaMasoud Mohammadi Original Article 22 June 2021 Pages: 4511 - 4525
Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis Aida Malek MahdaviMojtaba VarshochiAlireza Khabbazi Brief Report 29 June 2021 Pages: 4527 - 4531
Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis–related interstitial lung disease: a meta-analysis Sisi XieShu LiFen Li Original Article 29 June 2021 Pages: 4533 - 4543
Clinical and laboratory features, disease activity, and outcomes of juvenile systemic lupus erythematosus at diagnosis: a single-center study from southern China Wengen LiSudong LiuChao Chen Original Article 17 June 2021 Pages: 4545 - 4552
Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS) Enas I. AbdelhadyMona RabieRofaida A. Hassan Original Article 17 June 2021 Pages: 4553 - 4558
Strong association of common variants in the miRNA-binding site of NOD2 gene with clinicopathological characteristics and disease activity of systemic lupus erythematosus Emran EsmaeilzadehMostafa SaghiMehrdad Nasrollahzadeh Sabet Original Article 26 June 2021 Pages: 4559 - 4567
Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFα, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study Mariagrazia LorenzinAugusta OrtolanRoberta Ramonda Original Article Open access 16 June 2021 Pages: 4569 - 4580
Platelet distribution width is highly associated with thrombotic events in primary antiphospholipid syndrome Yu ShiHui JiangXiaofeng Zeng Original Article 02 July 2021 Pages: 4581 - 4588
Prevalence and risk factors for left ventricular diastolic dysfunction in systemic sclerosis: a multi-center study of CRDC cohort in China Min HuiJiaxin ZhouXiaofeng Zeng Original Article 17 June 2021 Pages: 4589 - 4596
Myocardial involvement in idiopathic inflammatory myopathies: a multi-center cross-sectional study in the CRDC-MYO Registry Zhang LixiZhu Huiyion behalf of Chinese Rheumatism Data Center-Myositis Registry (CRDC-MYO) Original Article 29 June 2021 Pages: 4597 - 4608
Development of an Arabic version of the Behçet’s Disease Current Activity Form (Ar-BDCAF): cross-cultural adaptation and validation initiative in Egypt Tamer A. GheitaHanan M. Fathion behalf of the Egyptian College of Rheumatology Study Group Original Article 25 June 2021 Pages: 4609 - 4618
Hip involvement in children with enthesitis related arthritis (ERA) is associated with poor outcomes in adulthood R. NaveenNamita MohindraAmita Aggarwal Original Article 25 June 2021 Pages: 4619 - 4627
Serum cartilage oligomeric matrix protein is correlated with quantitative magnetic resonance imaging and arthroscopic cartilage findings in anterior cruciate ligament deficient knees without osteoarthritic changes Yohei NishidaYusuke HashimotoHiroaki Nakamura Original Article 12 June 2021 Pages: 4629 - 4638
Quantification of bone marrow edema in rheumatoid arthritis by using high-speed T2-corrected multiecho acquisition of 1H magnetic resonance spectroscopy: a feasibility study Wenzhao YuanYiwu LeiLiling Long Original Article 21 June 2021 Pages: 4639 - 4647
Entheseal involvement of the lower extremities in gout: an ultrasonographic descriptive observational study Guanhua XuJin LinHeng Cao Original Article 22 June 2021 Pages: 4649 - 4657
Clinical impact of a personalized pharmaceutical plan on opioid management in non-cancer pain: a pilot study Claire LattardCatherine ChenaillerOlivier Vittecoq Brief Report 25 May 2021 Pages: 4659 - 4663
Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease Padmanabha ShenoySakir AhmedA. S. Sageer Babu Brief Report 22 June 2021 Pages: 4665 - 4670
Janus kinase inhibitors and major COVID-19 outcomes: time to forget the two faces of Janus! A meta-analysis of randomized controlled trials Dimitrios PatouliasMichael DoumasAsterios Karagiannis Brief Report 24 August 2021 Pages: 4671 - 4674
The clinical significance of a shortened activated partial thromboplastin time in patients with connective tissue disease Koji HabeHideo WadaKeiichi Yamanaka Original Article 16 June 2021 Pages: 4675 - 4683
Three new inflammatory markers C reactive protein to albumin ratio, neutrophil to lymphocyte ratio, and platelet to lymphocyte ratio correlated with relapsing polychondritis disease activity index Xiaoyu CaoMengzhu ZhaoXiaofeng Zeng Original Article 23 June 2021 Pages: 4685 - 4691
An analysis of scientometric data and publication policies of rheumatology journals Gokhan TazegulEmre EmreVeli Yazısız Original Article 24 June 2021 Pages: 4693 - 4700
Selected clinical parameters and changes in cardiac morphology and function assessed by magnetic resonance imaging in patients with rheumatoid arthritis and ankylosing spondylitis without clinically apparent heart disease Wojciech TańskiPaweł GaćAndrzej Szuba Original Article Open access 26 June 2021 Pages: 4701 - 4711
Evaluation of serum interleukin-6 (IL-6), IL-13, and IL-17 levels and computed tomography finding in interstitial lung disease associated with connective tissue disease patients Dilek TezcanAbdullah SivrikayaSema Yılmaz Original Article 14 June 2021 Pages: 4713 - 4724
Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up Rocío-V. Gamboa-CárdenasSilvia Barzola-CerrónManuel Ugarte-Gil Original Article 30 June 2021 Pages: 4725 - 4734
A bibliometric analysis of rheumatology and COVID-19 researches Ozge PasinTugce Pasin Original Article 02 July 2021 Pages: 4735 - 4740
Pleural effusion in psoriatic arthritis patients: a case series and review of the literature Aliki I. VenetsanopoulouTheodora E. MarkatseliParaskevi V. Voulgari Case Based Review 29 March 2021 Pages: 4741 - 4748
Psoriatic onycho-pachydermo periostitis (POPP): a case report treated successfully with IL-17 blockade and a literature review on characteristics, pathogenesis, and treatment Grigorios T. SakellariouIoannis TsifountoudisPeriklis Vounotrypidis Case Based Review 08 April 2021 Pages: 4749 - 4757
Engagement process for patients with spondyloarthritis: PANLAR early SpA clinics project — centers of excellence Pedro Santos-MorenoXenofon BaraliakosRodrigo García-Salinas Perspectives in Rheumatology 17 July 2021 Pages: 4759 - 4766
Linear morphea involving the underlying muscle Naoki YamamotoAkihiro DejimaKenkou Hasatani Clinical Image 27 May 2021 Pages: 4767 - 4768
Muehrcke’s lines in an adolescent boy with Kawasaki disease Himanshi ChaudharyVishnuvardhan Reddy KondaSurjit Singh Clinical Image 16 June 2021 Pages: 4769 - 4770
Bilateral thickened great auricular nerve in a case of Hansen’s arthropathy Prasanta PadhanDebashis Maikap Clinical Image 22 June 2021 Pages: 4771 - 4772
Depression and anxiety might not be increased during COVID-19 pandemic in patient with axial spondyloarthritis E. ErpekD. SolmazS. Akar Letters of Biomedical and Clinical Research 03 July 2021 Pages: 4773 - 4774
Impact of COVID-19 on hospitalization of patients with systemic lupus erythematosus (SLE) Wendy Wan Hui LeeYaw Kiet CheongBenjamin Sachdev Manjit Singh Letters of Biomedical and Clinical Research 11 September 2021 Pages: 4775 - 4777
A rebuttal letter to the letter ID number CLRH-D-21–00,836 entitled “On the efficacy and safety of rituximab therapy in patients with systemic sclerosis disease: missing points, bottlenecks, over-exaggeration and discrepancies” Maliheh MoradzadehMehrdad AghaeiNafiseh Abdollahi Letter to the Editor 13 September 2021 Pages: 4779 - 4780
Effect of hyperuricemia treatment on chronic kidney disease Tomoyuki Kawada Letter to the Editor 20 September 2021 Pages: 4781 - 4781
Correction to: An analysis of scientometric data and publication policies of rheumatology journals Gokhan TazegulEmre EmreVeli Yazısız Correction 22 July 2021 Pages: 4783 - 4786